JP2022022379A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022022379A5 JP2022022379A5 JP2021199543A JP2021199543A JP2022022379A5 JP 2022022379 A5 JP2022022379 A5 JP 2022022379A5 JP 2021199543 A JP2021199543 A JP 2021199543A JP 2021199543 A JP2021199543 A JP 2021199543A JP 2022022379 A5 JP2022022379 A5 JP 2022022379A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (1)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018205215A JP2019108320A (en) | 2018-10-31 | 2018-10-31 | Ophthalmologic composition which suppresses deterioration of soft contact lens |
| JP2018205215 | 2018-10-31 | ||
| JP2019198581A JP6992033B2 (en) | 2018-10-31 | 2019-10-31 | Ophthalmic composition that suppresses deterioration of soft contact lenses |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019198581A Division JP6992033B2 (en) | 2018-10-31 | 2019-10-31 | Ophthalmic composition that suppresses deterioration of soft contact lenses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022022379A JP2022022379A (en) | 2022-02-03 |
| JP2022022379A5 true JP2022022379A5 (en) | 2022-11-08 |
| JP7429681B2 JP7429681B2 (en) | 2024-02-08 |
Family
ID=67178967
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018205215A Pending JP2019108320A (en) | 2018-10-31 | 2018-10-31 | Ophthalmologic composition which suppresses deterioration of soft contact lens |
| JP2019198581A Active JP6992033B2 (en) | 2018-10-31 | 2019-10-31 | Ophthalmic composition that suppresses deterioration of soft contact lenses |
| JP2021199543A Active JP7429681B2 (en) | 2018-10-31 | 2021-12-08 | Ophthalmic composition that suppresses deterioration of soft contact lenses |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018205215A Pending JP2019108320A (en) | 2018-10-31 | 2018-10-31 | Ophthalmologic composition which suppresses deterioration of soft contact lens |
| JP2019198581A Active JP6992033B2 (en) | 2018-10-31 | 2019-10-31 | Ophthalmic composition that suppresses deterioration of soft contact lenses |
Country Status (4)
| Country | Link |
|---|---|
| JP (3) | JP2019108320A (en) |
| CN (1) | CN112969465A (en) |
| TW (1) | TWI832920B (en) |
| WO (1) | WO2020090895A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6963651B2 (en) * | 2020-04-16 | 2021-11-10 | 参天製薬株式会社 | Aqueous composition containing epinastine or a salt thereof |
| JP7118579B1 (en) | 2020-04-16 | 2022-08-16 | 参天製薬株式会社 | Aqueous composition containing epinastine or its salt |
| JP7114668B2 (en) * | 2020-10-08 | 2022-08-08 | 参天製薬株式会社 | Pollen burst inhibitor containing epinastine or its salt |
| EP4268825A1 (en) * | 2020-12-24 | 2023-11-01 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition for transdermal administration containing epinastine or salt thereof and containing sulfur-based antioxidant |
| CN113608363B (en) * | 2021-08-24 | 2023-04-14 | 江苏康耐特光学有限公司 | Front bending degree design method for preparing high-refractive-index resin lens |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19954516A1 (en) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Solutions containing epinastine |
| WO2007088783A1 (en) * | 2006-02-02 | 2007-08-09 | Menicon Co., Ltd. | Eye drop/wearing fluid for soft contact lenses |
| JP6751016B2 (en) * | 2014-03-31 | 2020-09-02 | ロート製薬株式会社 | Aqueous composition for ophthalmology or otolaryngology |
| WO2016190306A1 (en) * | 2015-05-28 | 2016-12-01 | ロート製薬株式会社 | Aqueous ophthalmic composition |
| JP6134853B1 (en) * | 2016-10-28 | 2017-05-24 | 参天製薬株式会社 | Epinastine-containing ophthalmic solution |
| JP6940276B2 (en) * | 2016-12-26 | 2021-09-22 | 小林製薬株式会社 | Pollen rupture inhibitor |
| JP6971570B2 (en) * | 2016-12-26 | 2021-11-24 | 小林製薬株式会社 | Pollen rupture inhibitor |
| JP7382731B2 (en) | 2018-04-23 | 2023-11-17 | ロート製薬株式会社 | Ophthalmic composition |
| JP7313181B2 (en) | 2018-04-23 | 2023-07-24 | ロート製薬株式会社 | ophthalmic composition |
| JP7355539B2 (en) * | 2018-07-20 | 2023-10-03 | ロート製薬株式会社 | Ophthalmic composition |
| JP7458159B2 (en) * | 2018-09-28 | 2024-03-29 | ロート製薬株式会社 | Ophthalmic Composition |
-
2018
- 2018-10-31 JP JP2018205215A patent/JP2019108320A/en active Pending
-
2019
- 2019-10-30 WO PCT/JP2019/042590 patent/WO2020090895A1/en active Application Filing
- 2019-10-30 CN CN201980071142.8A patent/CN112969465A/en active Pending
- 2019-10-30 TW TW108139295A patent/TWI832920B/en active
- 2019-10-31 JP JP2019198581A patent/JP6992033B2/en active Active
-
2021
- 2021-12-08 JP JP2021199543A patent/JP7429681B2/en active Active